SCHEMBL6695696

SCHEMBL6695696

CC(C)CC(NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)c1nc(C(=O)O)cs1

nearest known ligand 0.80

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CTSK P43235 14/20 0.80
CTSL P07711 6/20 0.80
CTSB P07858 4/20 0.80
CTSS P25774 3/20 0.55
CAPN1 P07384 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5934819 1.00 CTSK (0.80) CTSKCTSLCTSBCTSSCAPN1
SCHEMBL6987536 0.92 CTSK (0.75) CTSKCTSLCTSBCTSS
SCHEMBL6981246 0.92 CTSK (0.75) CTSKCTSLCTSBCTSS
SCHEMBL6683037 0.92 CTSK (0.76) CTSKCTSLCTSBCTSSCAPN1
SCHEMBL5934960 0.92 CTSK (0.76) CTSKCTSLCTSBCTSSCAPN1
SCHEMBL5935121 0.91 CTSK (0.75) CTSKCTSLCTSBCTSSCAPN1
SCHEMBL6681030 0.83 CTSK (0.64) CTSKCTSLCTSBCTSSCAPN1
SCHEMBL6686640 0.83 CTSK (0.64) CTSKCTSLCTSBCTSSCAPN1
SCHEMBL5934894 0.83 CTSK (0.64) CTSKCTSLCTSBCTSSCAPN1
SCHEMBL7165396 0.83 CTSK (0.78) CTSKCTSLCTSBCTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004058238-A1 USE OF CATHEPSIN K INHIBITORS FOR THE TREATMENT OF GLAUCOMA ALCON, INC. (CH) 2004-07-15 WO claimed
EP-0934291-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1999-08-11 EP disclosed
EP-0934291-A4 SMITHKLINE BEECHAM CORP (US) 1999-08-11 EP disclosed
WO-1997016433-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1997-05-09 WO disclosed